Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Choosing between price and cap weighting depends on your objectives and risk tolerance. This guide highlights strengths and trade-offs.
26,659 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
DraftKings is under renewed scrutiny as it rolls out Predictions and posts a mixed Q1 2026. Our price prediction: dkn...
Raymond James lifts Valero's price target to $290, arguing sustained refining margins and a structural advantage coul...
Investors watched Ford stock sink this week as the company faced a mix of softer sales signals, strategic bets on ene...
States expand aid to middle-income buyers as mortgage costs and home prices stay elevated. The shift broadens access ...
This comprehensive guide explains what frequent intraday trading is, who it suits, and how to manage risk with real-w...
Pfizer's stock has lagged since 2021, but the story isn’t over. This guide breaks down why pfizer stock: still priced...
A rare moment in tech investing brings a high-quality name into focus. This article explains why Microsoft may be a o...
Analysts say social security’s COLA could climb in 2027 as inflation holds steady and energy costs remain volatile du...
As a rare-earth supplier with the United States' only large-scale mine, MP Materials sits at a pivotal crossroads. If...
XRP trades near $1.50 in mid-May 2026 as traders weigh a potential move to $3 this year. Regulatory clarity and liqui...
Bitcoin’s Iran rally enters a 60-day test as a framework for sanctions relief unfolds. Oil volatility calms, but the ...